Drug Profile
Azathioprine oral dispersible - Mitsubishi Tanabe
Alternative Names: Azanin; JP azathioprine tabletsLatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer Mitsubishi Tanabe Pharma Corporation
- Class Antirheumatics; Purines; Small molecules; Thionucleosides
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Autoimmune hepatitis; Connective tissue disorders; Crohn's disease; Dermatomyositis; Polymyositis; Scleroderma; Systemic lupus erythematosus; Transplant rejection; Ulcerative colitis; Vasculitis